Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor

Stem Cells and Development

Volumn 23, Issue 4, 2014, Pages 352-362

  Anaraki, Parnian Kalbasi ^a   Patecki, Margret ^a   Larmann, Jan ^a   Tkachuk, Sergey ^a   Jurk, Kerstin ^b   Haller, Hermann ^a   Theilmeier, Gregor ^a   Dumler, Inna ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOGENIC DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; VASCULAR CALCIFICATION;

EID: 84893691388     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0318     Document Type: Article

References (54)

1. Schoengraf P, J Lambris, S Recknagel, L Kreja, A Liedert, R Brenner, M Huber-Lang and A Ignatius. (2013). Does complement play a role in bone development and regeneration? Immunobiology 218:1-9.
2. Schraufstatter I, R Discipio, M Zhao and S Khaldoyanidi. (2009). C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J Immunol 182:3827-3836.
3. Billiard J, R Moran, M Whitley, M Chatterjee-Kishore, K Gillis, E Brown, B Komm and P Bodine. (2003). Transcriptional profiling of human osteoblast differentiation. J Cell Biochem 89:389-400.
4. Ignatius A, P Schoengraf, L Kreja, A Liedert, S Recknagel, S Kandert, R Brenner, M Schneider, J Lambris and M Huber- Lang. (2011). Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1b. J Cell Biochem 112:2594-2605.
5. Ignatius A, C Ehrnthaller, R Brenner, L Kreja, P Schoengraf, P Lisson, R Blakytny, S Recknagel, L Claes, et al. (2011). The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro. J Trauma 71:952-960.
6. Shushakova N, G Eden, M Dangers, J Menne, F Gueler, FC Luft, H Haller and I Dumler. (2005). The urokinase/urokinase receptor system mediates the IgG immune complexinduced inflammation in lung. J Immunol 175:4060-4068.
7. Shushakova N, N Tkachuk, M Dangers, S Tkachuk, JK Park, J Zwirner, K Hashimoto, H Haller and I Dumler. (2005). Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor. J Cell Sci 118:2743-2753.
8. Vallabhaneni K, S Tkachuk, Y Kiyan, N Shushakova, H Haller, I Dumler and G Eden. (2011). Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells. Cardiovasc Res 90:113-121.
9. Ohishi M and E Schipani. (2009). Bone marrow mesenchymal stem cells. J Cell Biochem 109:277-282.
10. Law S and S Chaudhuri. (2013). Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells 2:22-38.
11. Cho H, H Cho, H Lee, M Song, J Seo, Y Bae, J Kim, H Lee, W Lee, et al. (2013). Vascular calcifying progenitor cells possess bidirectional differentiation potentials. PLoS Biol 11: e1001534.
12. Naik V, E Leaf, J Hu, H Yang, N Nguyen, C Giachelli and M Speer. (2012). Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 94:545-554.
13. Kramann R, S Couson, S Neuss, U Kunter, M Bovi, J Bornemann, R Knüchel, W Jahnen-Dechent, J Floege, and R Schneider. (2011). Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol 31:e45-e54.
14. Dewerchin M, AV Nuffelen, G Wallays, A Bouche, L Moons, P Carmeliet, RC Mulligan and D Collen. (1996). Generation and characterization of urokinase receptor-deficient mice. J Clin Invest 97:870-878.
15. Suzuki K, P Bose, R Leong-Quong, D Fujita and K Riabowol. (2010). REAP: a two minute cell fractionation method. BMC Res Notes 10:294.
16. Kiyan Y, R Kiyan, H Haller and I Dumler. (2005). Urokinaseinduced signaling in human vascular smooth muscle cells are mediated by PDGFR-β. EMBO J 24:1787-1797.
17. Hegner B, M Weber, D Dragun and E Schulze-Lohoff. (2005). Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J Hypertens 23:1191-1202.
18. Chen J, HC Park, F Addabbo, J Ni, E Pelger, H Li, M Plotkin and MS Goligorsky. (2008). Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kindey Int 74:879-879.
19. Kim YM, ES Jeon, MR Kim, SK Jho, SW Ryu and JH Kim. (2008). Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth musclelike cells. Int J Biochem Cell Biol 40:2482-2491.
20. Ross JJ, Z Hong, B Willenbring, L Zeng, B Isenberg, EH Lee, M Reyes, SA Keirstead, EK Weir, RT Tranquillo and CM Verfaillie. (2006). Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 116:3139-3149.
21. Molchadsky A, I Shats, N Goldfinger, M Pevsner-Fischer, M Olson, A Rinon, E Tzahor, G Lozano, D Zipori, R Sarig and V Rotter. (2008). p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One 3:e3707.
22. Tamama K, CK Sen and A Wells. (2008). Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17:897-908.
23. Kiyan Y, A Limbourg, R Kiyan, S Tkachuk, F Limbourg, A Ovsianikov, B Chichkov, H Haller and I Dumler. (2012). Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arterioscler Thromb Vasc Biol 32:110-122.
24. Byon C, Y Sun, J Chen, K Yuan, X Mao, J Heath, P Anderson, Y Tintut, L Demer, D Wang and Y Chen. (2011). Runx2- upregulated receptor activator of nuclear factor kB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler Thromb Vasc Biol 31:1387-1396.
25. Osako M, H Nakagami, M Shimamura, H Koriyama, F Nakagami, H Shimizu, T Miyake, M Yoshizumi, H Rakugi and R Morishita. (2013). Cross-talk of receptor activator of nuclear factor-kB ligand signaling with renin-angiotensin system in vascular calcification. Arterioscler Thromb Vasc Biol 33:1287-1296.
26. Chen X, C Hu, G Wang, L Li, X Kong, Y Ding and Y Jin. (2013). Nuclear factor-kB modulates osteogenesis of peri- odontal ligament stem cells through competition with b-catenin signaling in inflammatory microenvironments. Cell Death Dis 4:e510.
27. Mastellos D and J Lambris. (2002). Complement: more than a guard against invading pathogens? Trends Immunol 23.
28. Sarma J and P Ward. (2012). New developments in C5a receptor signaling. Cell Health Cytoskelet 4:73-82.
29. Sasaki T, KNakamura, K Sasada, SOkada, X Cheng, T Suzuki, T Murohara, K Sato and M Kuzuya. (2013). Matrix metalloproteinase- 2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice. Atherosclerosis 227:43-50.
30. Farris S, J Hu, R Krishnan, I Emery, T Chu, L Du, M Kremen, H Dichek, E Gold, S Ramsey and D Dichek. (2011). Mechanisms of urokinase plasminogen activator (uPA)- mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins. J Biol Chem 286:22665-22677.
31. Kiyan J, A Kusch, S Tkachuk, J Kramer, R Dietz, G Smith and I Dumler. (2007). Urokinase receptor and RhoA mediate non-lipid lowering effects of rosuvastatin on vascular remodeling. Atheriosclerosis 195:254-261.
32. Zhu D, N Mackenzie, C Farquharson and V Macrae. (2012). Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) 3:95.
33. Sage A, Y Tintut and L Demer. (2010). Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528-536.
34. Fadini G, M Rattazzi, T Matsumoto, T Asahara and S Khosla. (2012). Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 125:2772-2781.
35. Binder BR, J Mihaly and GW Prager. (2007). uPAR-uPA-PAI- 1 interactions and signaling: a vascular biologists view. Thromb Haemost 97:336-342.
36. Blasi F and P Carmeliet. (2002). uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932-943.
37. Furlan F, C Galbiati, N Jorgensen, J Jensen, E Mrak, A Rubinacci, F Talotta, P Verde and F Blasi. (2007). Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J Bone Miner Res 22:1387-1396.
38. Naves M, M Rodríguez-García, J Díaz-López, C Gómez- Alonso and J Cannata-Andía. (2008). Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporosis Int 19:8.
39. Simon S, D Fodor, L Muntean, L Poanta, P Cristea and S Rednic. (2013). Bone mineral density, vertebral fractures and body mass index in postmenopausal women with abdominal aortic calcification. Endocr Res [Epub ahead of print]; DOI: 10.3109/07435800.2013.794425.
40. Larmann J, T Frenzel, A Hahnenkamp, C Herzog, A Lorenz, A Steinbicker, S Calmer, T Harendza, M Schmitz, et al. (2010). Theilmeier, In vivo fluorescence-mediated tomography for quantification of urokinase receptor-dependent leukocyte trafficking in inflammation. Anesthesiology 113:610-618.
41. Fuhrman B. (2012). The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 222:8-14.
42. Cao Q, S McIsaac and A Stadnyk. (2012). Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am J Physiol Cell Physiol 302:C1731-C1740.
43. Abedin M, Y Tintut and L Demer. (2004). Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24:1161-1170.
44. Bennett M. (2002). Breaking the Plaque: evidence for Plaque Rupture in Animal Models of Atherosclerosis. Arterioscler Thromb Vasc Biol 22:713-714.
45. Cullen P, R Baetta, S Bellosta, F Bernini, G Chinetti, A Cignarella, A von Eckardstein, A Exley, M Goddard, et al. (2003). Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vasc Biol 23:529-534.
46. Johnson J, K Carson, H Williams, S Karanam, A Newby, G Angelini, S George and C Jackson. (2005). Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 111:1422-1430.
47. Sasaki T, M Kuzuya, K Nakamura, X Cheng, T Shibata, K Sato and A Iguchi. (2006). A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 26:1304-1309.
48. Yao Y, B Bennett, X Wang, M Rosenfeld, C Giachelli, A Lusis and K Boström. (2010). Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res 107:485-494.
49. OBrien E, M Garvin, D Stewart, T Hinohara, J Simpson, S Schwartz and C Giachelli. (1994). Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb Vasc Biol 14:1641-1647.
50. Abedin M, Y Tintut and LL Demer. (2004). Mesenchymal stem cells and the artery wall. Circ Res 95:671-676.
51. Wei X, X Yang, Z Han, F Qu, L Shao and Y Shi. (2013). Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34:747-754.
52. Liao J, X Chen, Y Li, Z Ge, H Duan, Y Zou and J Ge. (2012). Transfer of bone-marrow-derived mesenchymal stem cells influences vascular remodeling and calcification after balloon injury in hyperlipidemic rats. J Biomed Biotechnol 2012.
53. George J, A Afek, A Abashidze, H Shmilovich, V Deutsch, J Kopolovich, H Miller and G Keren. (2005). Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25: 2636-2641.
54. Yoon Y, J Park, T Tkebuchava, C Luedeman and D Losordo. (2004). Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109:3154-3157.